Clinical Trial of Comparing DA-2902 and DA-2902-R in Healthy Adult Subjects

Dong-A ST

Status and phase: Invitation-only; Phase 1

Conditions: Infective Disorder

Treatments: Drug: DA-2902; Drug: DA-2902-R

Study type: Interventional

Funder types: Industry

Identifiers

NCT07239453

DA2902_BE_I

Details and patient eligibility

About

This study is to compare pharmacokinetics and safety profiles of DA-2902 and DA-2902-R in healthy adult subjects

Enrollment: 40 estimated patients

Sex: All

Ages: 19 to 44 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Healthy volunteers
• BMI between 18 and 30 kg/m2
• Body weight: Male≥50kg, Female≥45kg
• Subjects who have signed an informed consent themselves after receiving detailed explanation about clinical study

Exclusion criteria

• Subjects with clinically significant medical history
• Subjects with history of drug abuse or addicted
• Subjects with allergy or drug hypersensitivity

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Crossover Assignment

Masking: None (Open label)

---

40 participants in 2 patient groups

Sequence A

Experimental group

Treatment:

Drug: DA-2902-R

Drug: DA-2902

Sequence B

Experimental group

Treatment:

Drug: DA-2902-R

Drug: DA-2902